NAGTRI Resources and Training on the Legal and Policy Implications for COVID-19 Vaccines
On December 11, 2020, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Pfizer-BioNTech vaccine to prevent COVID-19 among individuals 16 years of age and older. The following week, the FDA granted a separate EUA for the Moderna COVID-19 vaccine for those 18 years and older. Within twenty-four hours…
